1. Introduction
===============

Urotensin II (UII) is an eleven amino acid cyclic peptide produced from prepro-UII and exhibit full activity in different tissues including the cardiovascular system \[[@B1-ijms-16-12482]\]. UII and its receptor (UT), one of the G protein-coupled receptors (GPCRs), GPR14, are highly expressed in the cardiovascular system and upregulated in pathological conditions such as acute myocardial infarction \[[@B2-ijms-16-12482]\] or chronic hypoxic myocardium \[[@B3-ijms-16-12482]\], suggesting its role in cardiac remodeling. UII has showed a marked mitogenic and proliferative effect on vascular cells \[[@B4-ijms-16-12482]\]. It also affects the apoptosis, hypertrophy, fibrosis, and the inflammation process in various kinds of cells in the cardiovascular system \[[@B2-ijms-16-12482],[@B5-ijms-16-12482],[@B6-ijms-16-12482]\]. However, the effects of UII on cardiovascular function in pathological conditions are still controversial and remain to be explained. Plasma UII has been observed to be raised in patients with acute myocardial infarction and a lower UII response is associated with more severe injury of myocardium \[[@B7-ijms-16-12482]\], indicating a possible cardioprotective role for this peptide. It has been reported that UII can protect the heart against ischemia-reperfusion (I/R) through enhancing coronary flow and reducing cardiac contractility \[[@B8-ijms-16-12482]\]. Reactive oxygen species (ROS) and antioxidant pathway are involved in the protective effect of UII \[[@B9-ijms-16-12482]\]. However, the detailed molecular mechanisms are unclear.

Hydrogen sulfide (H~2~S) emerges as the third physiologically relevant gasotransmitter alongside nitric oxide (NO) and carbon monoxide \[[@B10-ijms-16-12482],[@B11-ijms-16-12482]\]. The production of H~2~S in mammalian systems has been attributed to three principal enzymes: cystathionine-β-synthase (CBS), cystathionine-γ-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (3-MST). CBS is the predominant source of H~2~S in the central nervous system (CNS). CSE is the major H~2~S-producing enzyme in cardiovascular system, although 3-MST is also expressed in the vascular endothelium \[[@B10-ijms-16-12482],[@B12-ijms-16-12482]\]. It has been reported that H~2~S exerts cytoprotective effects in various models of cardiac injury including I/R injury \[[@B13-ijms-16-12482]\], and suppresses fibrosis by reducing the expression of UII and inhibiting the activation of hepatic stellate cells \[[@B14-ijms-16-12482]\]. But the relationship between UII and H~2~S in injured cardiomyocytes is poorly understood.

Here, we treat cultured cardiomyocytes with H~2~O~2~ to induce oxidative stress, observe the influence of UII on H~2~O~2~-induced apoptosis and detect the production of H~2~S to explore the underlying mechanisms.

2. Results and Discussion
=========================

2.1. UII Prevents Cardiomyocytes from Apoptosis Induced by H~2~O~2~
-------------------------------------------------------------------

Real-time PCR analysis showed UII mRNA expression was increased significantly in left ventricle tissues at two days after myocardial infarction ([Figure S1](#app1-ijms-16-12482){ref-type="app"}A). We then explored whether UII can protect cardiomyocytes from apoptosis induced by oxidative stress *in vitro*. According to previous studies \[[@B15-ijms-16-12482],[@B16-ijms-16-12482]\], 100 μM H~2~O~2~ was used to induce oxidative stress-related apoptosis in cardiomyocytes. First, the effect of UII (0.1 µM) \[[@B17-ijms-16-12482]\] on apoptosis induced by H~2~O~2~ was assessed by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay (TUNEL) in cardiomyocytes. UII pre-treatment significantly reduced the number of TUNEL-positive cardiomyocytes induced by H~2~O~2~. SiRNA targeted UT (si-UT) partly abolished the anti-apoptotic effect of UII ([Figure 1](#ijms-16-12482-f001){ref-type="fig"}A,B). Bax and Bcl-2 have been reported to be a pro-apoptotic protein and an anti-apoptotic protein, respectively \[[@B18-ijms-16-12482]\]. Western blot analysis revealed that H~2~O~2~-treated-cardiomyocytes displayed a significant increase in the level of the pro-apoptotic protein Bax and a decrease in the level of anti-apoptotic protein Bcl-2. But UII greatly prevent the effects, and si-UT significantly suppressed the decrease of Bax and the increase of Bcl-2 induced by UII in H~2~O~2~-treated-cardiomyocytes ([Figure 1](#ijms-16-12482-f001){ref-type="fig"}C,D). These data suggest that UII prevents H~2~O~2~-treated-cardiomyocytes from apoptosis by UT.

UII is a somatostatin-like cyclic peptide synthesized by proteolytic cleavage from prepro-UII that stimulates its receptor (UT) to modulate cardiovascular function in humans and in other animal species \[[@B19-ijms-16-12482],[@B20-ijms-16-12482]\]. The UII/UT receptor-system is expressed widely within the cardiovascular system, and the expression is upregulated in human cardiovascular disease states, including congestive heart failure, essential hypertension, coronary artery disease, type II diabetes, and diabetic nephropathy \[[@B21-ijms-16-12482]\].

The present study showed UII mRNA expression was increased in left ventricle tissues after myocardial infarction. Human UII also causes positive inotropy in human and rat myocardium \[[@B22-ijms-16-12482],[@B23-ijms-16-12482]\], hypertrophic response in cardiomyocytes, and mitogenesis in vascular smooth muscle cells \[[@B24-ijms-16-12482]\] and cardiac fibroblasts \[[@B25-ijms-16-12482]\]. These studies indicate that UII/UT is involved in the development and/or progression of cardiovascular diseases, and the UT receptor is emerging as a promising target for therapeutic intervention \[[@B26-ijms-16-12482]\]. However, a protective effect of UII on the cardiovascular system has been demonstrated recently \[[@B27-ijms-16-12482]\]. In animal models, UII exerts beneficial effects on cardiac injury against ischemic-reperfusion by enhancing coronary flow, reducing cardiac contractility and infarction area \[[@B8-ijms-16-12482],[@B28-ijms-16-12482]\]. In patients with acute myocardial infarction, circulating UII levels are raised which is associated with improved clinical outcomes \[[@B7-ijms-16-12482]\]. We speculate that the contradictory effects of UII may depend on the pathophysiological conditions during cardiovascular diseases. But the molecular mechanisms for the protective effect of UII on cardiomyocytes are unclear.

2.2. UII Increases the H~2~S Production by Enhancing the Level of CSE (Cystathionine-γ-Lyase) in Cardiomyocytes Exposed to H~2~O~2~
-----------------------------------------------------------------------------------------------------------------------------------

Recently, H~2~S has been reported to protect against apoptosis in cardiomyocytes stimulated with isoproterenol \[[@B29-ijms-16-12482]\] or oxidative stress \[[@B30-ijms-16-12482],[@B31-ijms-16-12482]\]. We therefore studied the effect of UII on H~2~S production in cardiomyocytes. UII treatment sharply increased the production of H~2~S in cardiomyocytes in time-dependent manner. After 24 h, H~2~S production increased more than three-fold in UII-treated-cardiomyocytes, when compared with control ([Figure 2](#ijms-16-12482-f002){ref-type="fig"}A). H~2~O~2~ has little effect on the production of H~2~S in cardiomyocytes, but UII-pretreatment greatly increased H~2~S production, and si-UT partly abolished the effect of UII in H~2~O~2~-treated-cardiomyocytes ([Figure 2](#ijms-16-12482-f002){ref-type="fig"}B). Endogenous H~2~S is usually produced by CBS or CSE in mammalian systems. CSE is the major H~2~S-producing enzyme in the cardiovascular system \[[@B10-ijms-16-12482],[@B12-ijms-16-12482]\]. Reverse transcription PCR showed that CSE mRNA, not CBS mRNA, was detected in cultured cardiomyocytes ([Figure 2](#ijms-16-12482-f002){ref-type="fig"}C). Western blot analysis revealed that UII significantly upregulated the level of CSE in cardiomyocytes in a time-dependent manner ([Figure 2](#ijms-16-12482-f002){ref-type="fig"}D). At two days after myocardial infarction, UII mRNA level was increased about three-fold compared to that in the sham group, and CSE expression was upregulated accordingly after myocardial infarction ([Figure S1](#app1-ijms-16-12482){ref-type="app"}B,D). In cultured cardiomyocytes, H~2~O~2~ did not affect the CSE level but UII greatly increased the level in the presence of H~2~O~2~, and the effect was partly abolished by si-UT ([Figure 2](#ijms-16-12482-f002){ref-type="fig"}E). These data revealed that UII promoted H~2~S production by upregulating CSE level in H~2~O~2~-treated-cardiomyocytes.

![UII prevents cardiomyocytes from apoptosis induced by H~2~O~2~. (**A**) Detection of apoptotic cardiomyocytes (brown nuclei) by TUNEL staining; (**B**) Quantitative analysis of TUNEL positive cells, the data were represented as the percentage of TUNEL positive nuclei; (**C**) Western blot analysis of the level of Bax and Bcl-2 proteins; (**D**) Quantitative analysis of the ratio of Bax/Bcl-2 expression. The cultured cardiomyocytes were transfected with siRNA-UT (si-UT) or siRNA-scramble (as control) for 48 h, then treated with UII (0.1 μM) or PBS for 30 min and exposed to 100 μM H~2~O~2~ for 24 h. si-UT: Cardiomyocytes were transfected with siRNA-UT. Cardiomyocytes were transfected with siRNA-scramble (si-scram) as control. Values are mean ± SEM. **\*** *p* \< 0.05 *vs.* PBS group; ^\#^ *p* \< 0.05 *vs.* H~2~O~2~ group; ^&^ *p* \< 0.05 *vs.* H~2~O~2~ + UII group. Bar = 25 μm. All experiments were repeated independently at least three times.](ijms-16-12482-g001){#ijms-16-12482-f001}

![UII increases the production of H~2~S by enhancing the level of CSE in cardiomyocytes exposed to H~2~O~2~. (**A**) H~2~S production was examined in culture supernatant of cardiomyocytes treated with UII at different time points (0, 12, 24, 48 h). Values are mean ± SEM. **\*** *p* \< 0.05, **\*\*** *p* \< 0.01 *vs.* 0 h group; ^\#^ *p* \< 0.05 *vs.* 12 h group; (**B**) H~2~S production was examined in culture medium of cardiomyocytes transfected with si-UT or siRNA-scramble for 48 h, then treated with UII (0.1 μM) or PBS for 30 min and exposed to 100 μM H~2~O~2~ for 24 h. si-UT: Cardiomyocytes (CMs) were transfected with siRNA-UT, or siRNA-scramble as control. Values are mean ± SEM. **\*** *p* \< 0.05, **\*\*** *p* \< 0.01 *vs.* H~2~O~2~ group; ^\#\#^ *p* \< 0.01 *vs.* H~2~O~2~ + UII group; (**C**) RT-PCR analysis of CBS and CSE mRNA expression in cultured cardiomyocytes. The expression of CBS and CSE mRNAs in liver tissue was detected as positive control; (**D**) Western blot analysis of CSE level in cardiomyocytes treated with UII at different time points (0, 12, 24, 48 h). Values are mean ± SEM. **\*** *p* \< 0.05 *vs.* 0 h group; ^\#^ *p* \< 0.05 *vs.* 12 h group; (**E**) Western blot analysis of CSE level in cardiomyocytes transfected with si-UT or siRNA-scramble for 48 h, then treated with UII (0.1 μM) or PBS for 30 min and exposed to 100 μM H~2~O~2~ for 24 h. CMs: Cardiomyocytes. Si-UT: CMs were transfected with siRNA-UT; Si-scram: CMs were transfected with siRNA-scramble as control. Values are mean ± SEM. **\*** *p* \< 0.05 *vs.* H~2~O~2~ group; ^\#^ *p* \< 0.05 *vs.* H~2~O~2~ + UII group. All experiments were repeated independently at least three times.](ijms-16-12482-g002){#ijms-16-12482-f002}

In recent years, H~2~S, a physiologically relevant gasotransmitter, has been demonstrated to have cytoprotective effects in multiple organ systems including heart. Administration of H~2~S significantly ameliorates myocardial ischaemia--reperfusion injury \[[@B32-ijms-16-12482]\]. Oxidative stress-induced-apoptosis of cardiomyocytes plays critical role in cardiac dysfunction during ischaemia-reperfusion \[[@B33-ijms-16-12482]\]. H~2~S exerts antioxidative effects to protect against apoptosis of cardiomyocytes under oxidative stress through the SIRT1 pathway \[[@B31-ijms-16-12482]\]. In addition, H~2~S may protect the heart or cardiomyocytes against ischemic preconditioning by promoting nitric oxide (NO) release, activating sarcolemmal adenosine triphosphate sensitive K^+^ channel (KATP) \[[@B34-ijms-16-12482]\] or ameliorating intracellular Ca^2+^ handling \[[@B35-ijms-16-12482]\]. UII and its receptor has been reported to be upregulated in ischemic heart tissue \[[@B2-ijms-16-12482]\]. Zhu *et al.* reported that acute myocardial infarction induced the accumulation of CSE in ischemic myocardium \[[@B36-ijms-16-12482]\]. The present data revealed that UII level and CSE expression were upregulated in myocardium after acute myocardial infarction. It indicates that the increased UII may upregulate the expression of CSE under myocardial ischemia. The present data showed that UII enhanced CSE level and H~2~S production which may be involved in the protective role of UII on cardiomyocytes under oxidative stress.

2.3. UII Promotes the Activation of ERK in Cultured Cardiomyocytes Exposed to H~2~O~2~
--------------------------------------------------------------------------------------

It has been reported that UII activates ERK to induce cardiomyocytes hypertrophy \[[@B21-ijms-16-12482]\]. ERK is involved in cardioprotection against ischemia \[[@B37-ijms-16-12482],[@B38-ijms-16-12482]\]. The study showed that p-ERK was greatly increased in ventricular tissue at two days after myocardial infarction ([Figure S1](#app1-ijms-16-12482){ref-type="app"}B,D). To explore whether it is involved in the effect of UII on H~2~S production, we detected the p-ERK level in cardiomyocytes. UII increased p-ERK level in cultured cardiomyocytes in a time-dependent manner ([Figure 3](#ijms-16-12482-f003){ref-type="fig"}A). The level of p-ERK was slightly increased by H~2~O~2~ treatment, but it was greatly upregulated by UII, and the effect was significantly inhibited by si-UT in H~2~O~2~-treated-cardiomyocytes ([Figure 3](#ijms-16-12482-f003){ref-type="fig"}B,C). From our data, we speculate that UII-promoted-activation of ERK may contribute to the increased CSE level and subsequently upregulated endogenous H~2~S production to protect cardiomyocytes against H~2~O~2~. ERK, one of the important mediators of signal transduction from the cell membrane to cytosol or nucleus, is activated by multiple stimuli including ischemia \[[@B39-ijms-16-12482],[@B40-ijms-16-12482]\]. The increased UII level in ischemic heart tissue may be involved in the activation of ERK mediated by the UT pathway. UT (GPR14) belongs to the GPCR family, which is involved in the activation of ERK with multiple mechanisms. G-protein dependent signals probably promotes epidermal growth factor receptor (EGFR) transactivation and then leads to activation of ERK, accounting for the stimulation of Elk1-dependent transcription \[[@B41-ijms-16-12482]\]. In contrast, upon the activation of GPCRs, the binding of cytosolic β-arrestins to ERKs induces the activation of ERK, which may phosphorylate cytosolic kinases involved in multiple regulation \[[@B41-ijms-16-12482]\]. Esposito *et al.* \[[@B42-ijms-16-12482]\] reported that UII induced translocation of β-arrestin 1/2 and EGFR phosphorylation which contributes to the activation of ERK, promoting cell survival and cardioprotection during pressure overload. The activation of integrin-mediated signaling pathways has been reported to be involved in UII-induced phosphorylation of ERK in vascular smooth muscle cells (VSMCs) \[[@B43-ijms-16-12482]\]. In addition, extracellular superoxide dismutase (SOD3) induces ERK activation, which decreases apoptosis in a rat hind limb injury model \[[@B40-ijms-16-12482]\] or in the late stages of the aortopathy \[[@B44-ijms-16-12482]\]. In the present study, UII may activate the ERK pathway through these mechanisms; whether other pathways are involved in the process needs further study.

![UII promotes the activation of ERK in cultured cardiomyocytes exposed to H~2~O~2~. (**A**) Western blot analysis of p-ERK level in cultured cardiomyocytes treated with UII at different time points (0, 10, 30, 60, 120, 240 min); (**B**) Western blot analysis of p-ERK level in cardiomyocytes; (**C**) Quantitative analysis of p-ERK/ERK level in cultured cardiomyocytes. Cardiomyocytes were transfected with si-UT or siRNA-scramble for 48 h, then treated with UII (0.1 μM) or PBS for 30 min and exposed to 100 μM H~2~O~2~ for 10 min. si-UT: CMs were transfected with siRNA-UT, other CMs were transfected with siRNA-scramble (si-scram) as control. Values are mean ± SEM. ^&^ *p* \< 0.05 *vs.* PBS group. **\*** *p* \< 0.05, **\*\*** *p* \< 0.01 *vs.* H~2~O~2~ group; ^\#^ *p* \< 0.05 *vs.* H~2~O~2~ + UII group. All experiments were repeated independently at least three times.](ijms-16-12482-g003){#ijms-16-12482-f003}

2.4. UII Induces the Reciprocal Regulation of CSE and ERK in Cardiomyocytes Exposed to H~2~O~2~
-----------------------------------------------------------------------------------------------

In order to detect the relationship between the increased CSE expression and ERK phosphorylation induced by UII, cardiomyocytes were transfected with siRNA targeted CSE (si-CSE), or treated with the ERK inhibitor, 1,4-diamino-2,3-dicyano-1,4-*bis*(2-aminophenylthio)butadiene (U0126). P-ERK level and CSE levels were detected. Si-CSE effectively mediated knockdown of the expression of CSE in cultured cardiomyocytes, and it greatly inhibited the activation of ERK induced by UII in cardiomyocytes exposed to H~2~O~2~ ([Figure 4](#ijms-16-12482-f004){ref-type="fig"}A,C). ERK, one of the MAPK superfamily, is involved in cellular survival and apoptotic process \[[@B45-ijms-16-12482]\]. Here, we provide evidence that UII-induced-activation of ERK was inhibited by si-CSE in H~2~O~2~-treated-cardiomyocytes. It is reasoned that ERK activation is involved in CSE/H~2~S-mediated-anti-apoptosis in cardiomyocytes under oxidative stress. These findings are in line with a previous study that CSE overexpression mediated protective effects associated with an increased ERK activation in VSMCs \[[@B46-ijms-16-12482]\].

![UII induces the reciprocal regulation of CSE and ERK in cardiomyocytes exposed to H~2~O~2~. Representative image of p-ERK, ERK, CSE (**A**) and quantitative analysis of p-ERK/ERK level (**B**) by Western blot analysis in cultured cardiomyocytes. Cardiomyocytes were transfected with si-scramble or si-CSE for 48 h, treated with UII (0.1 μM) or PBS for 30 min, then exposed to 100 μM H~2~O~2~ for 10 min, analyzed for p-ERK and ERK levels, or exposed to 100 μM H~2~O~2~ for 24 h, and analyzed for CSE level. Values are mean ± SEM. **\*\*** *p* \< 0.01, UII + si-scram *vs.* Si-scram or UII + si-CSE *vs.* Si-CSE. ^\#^ *p* \< 0.05, UII + si-CSE *vs.* UII + si-scram. Representative image of p-ERK, ERK, CSE (**C**) and quantitative analysis of p-ERK/ERK level (**D**) by Western blot analysis in cultured cardiomyocytes. Cultured cardiomyocytes were treated with DMSO or U0126 with or without UII for 30 min, then exposed to 100 μM H~2~O~2~ for 10 min, analyzed for p-ERK and ERK level, or exposed to 100 μM H~2~O~2~ for 24 h, and analyzed for CSE level. Values are mean ± SEM. **\*** *p* \< 0.05, UII + DMSO *vs.* DMSO or UII + U0126 *vs.* UII + DMSO. ^\#^ *p* \< 0.05, UII + U0126 *vs.* UII + DMSO. All experiments were repeated independently at least three times.](ijms-16-12482-g004){#ijms-16-12482-f004}

Further analysis showed that the ERK inhibitor, U0126, greatly inhibited not only the phosphorylation of ERK, but also the increased CSE level induced by UII in cardiomyocytes in the presence of H~2~O~2~ ([Figure 4](#ijms-16-12482-f004){ref-type="fig"}B,D). The data revealed that ERK activation may participate in the up-regulation of CSE by UII. CSE expression is regulated by some transcription factors including Elk1 \[[@B47-ijms-16-12482]\]. It has been reported that Elk1 is usually activated by phosphorylation, then interacts with the promoter of CSE and enhances its expression \[[@B47-ijms-16-12482]\] via an ERK-dependent mechanism in liver tissue \[[@B48-ijms-16-12482]\]. Activated ERK, is free to enter the nucleus, and phosphorylates Elk1, contributing to Elk1-dependent transcription \[[@B41-ijms-16-12482]\]. Therefore, UII-induced activation of ERK may account for the increased CSE expression in H~2~O~2~-treated-cardiomyocytes by Elk1 activation. Zhu *et al.* \[[@B49-ijms-16-12482]\] reported that estrogen increased CSE expression and H~2~S generation in the myocardium of ovariectomized rats *in vivo*, but clarification of the mechanisms need further study.

These data suggest that UII induces H~2~S production through increasing CSE levels and the phosphorylation of ERK, which may contribute to the anti-apoptotic effect of UII on cardiomyocytes exposed to H~2~O~2~.

2.5. Si-CSE or ERK Inhibitor Partly Abolishes Anti-Apoptotic Effects of UII on H~2~O~2~-Treated Cardiomyocytes
--------------------------------------------------------------------------------------------------------------

Cardiomyocytes were transfected with si-CSE, and treated with ERK inhibitor, U0126, respectively. The levels of Bax and Bcl-2 were detected in H~2~O~2~-treated-cardiomyocytes with or without UII pretreatment. Cardiomyocyte apoptosis was analyzed by TUNEL analysis. The results revealed that ERK inhibitor, U0126, or si-CSE reversed the increase in Bcl-2 level and decrease in Bax level induced by UII in cardiomyocytes exposed to H~2~O~2~ ([Figure 5](#ijms-16-12482-f005){ref-type="fig"}A--D). TUNEL analysis showed that UII greatly decreased the number of TUNEL positive cardiomyocytes, but the effect was significantly inhibited by si-CSE or ERK inhibitor in H~2~O~2~-treated-cardiomyocytes ([Figure 6](#ijms-16-12482-f006){ref-type="fig"}A--C).

![Si-CSE or ERK inhibitor partly abolishes the downregulation of Bax/Bcl-2 induced by UII on H~2~O~2~-treated-cardiomyocytes. Representative image of Bax and Bcl-2 (**A**) and quantitative analysis of Bax/Bcl-2 (**B**) by Western blot analysis in cultured cardiomyocytes transfected with si-scramble or si-CSE for 48 h, treated with UII or PBS for 30 min, then exposed to 100 μM H~2~O~2~ for 24 h. Values are mean ± SEM. **\*** *p* \< 0.05, **\*\*** *p* \< 0.01, UII + si-scram *vs.* Si-scram or UII + si-CSE *vs.* Si-CSE. ^\#^ *p* \< 0.05 UII + si-CSE *vs.* UII + si-scram. Representative image of Bax and Bcl-2 (**C**) and quantitative analysis of Bax/Bcl-2 (**D**) by Western blot analysis in cultured cardiomyocytes treated with DMSO or U0126 with or without UII for 30 min and exposed to 100 μM H~2~O~2~ for 24 h. Values are mean ± SEM. **\*\*** *p* \< 0.01, UII + DMSO *vs.* DMSO or UII + U0126 *vs.* UII + DMSO. ^\#^ *p* \< 0.05, UII + U0126 *vs.* UII + DMSO. All experiments were repeated independently at least three times.](ijms-16-12482-g005){#ijms-16-12482-f005}

![Si-CSE or ERK inhibitor partly abolishes the anti-apoptotic effects of UII on H~2~O~2~-treated-cardiomyocytes. (**A**) Representative images of TUNEL staining in cultured cardiomyocytes. Bar = 25 μm; (**B**) Quantitative analysis of TUNEL staining in cultured cardiomyocytes transfected with si-scramble or si-CSE for 48 h, treated with UII (0.1 μM) or PBS for 30 min, then exposed to 100 μM H~2~O~2~ for 24 h. Values are mean ± SEM. **\*** *p* \< 0.05, **\*\*** *p* \< 0.01, UII + si-scram *vs.* Si-scramb or UII + si-CSE *vs.* Si-CSE. ^\#^ *p* \< 0.05. UII + si-CSE *vs.* UII + si-scram; (**C**) Quantitative analysis of TUNEL staining in cultured cardiomyocytes treated with DMSO or U0126 with or without UII for 30 min and exposed to 100 μM H~2~O~2~ for 24 h. Values are mean ± SEM. **\*** *p* \< 0.05, **\*\*** *p* \< 0.01, UII *vs.* DMSO or UII + U0126 *vs.* UII + DMSO. ^\#\#^ *p* \< 0.01 UII + U0126 *vs.* UII + DMSO. All experiments were repeated independently at least three times.](ijms-16-12482-g006){#ijms-16-12482-f006}

On the one hand, UII upregulated CSE levels which promoted H~2~S production. The CSE/H~2~S pathway plays an important role in anti-apoptosis against oxidative stress in cardiomyocytes through SIRT or NO signaling as discussed above. On the other hand, UII-induced-activation of ERK may function in another manner to promote survival of cardiomyocytes under oxidative stress. ERK activation has been reported to induce iNOS expression \[[@B50-ijms-16-12482]\] or NF-κB/p65 nucleus translocation \[[@B51-ijms-16-12482]\], which inhibits cell apoptotic processes in other types of cells.

Taken together, these data demonstrate that UII activates ERK rapidly, and the activation of ERK increases CSE level and H~2~S production; in turn, they further upregulate the p-ERK level, which contributes to the anti-apoptotic effect of UII on the cardiomyocytes exposed to H~2~O~2~.

3. Experimental Section
=======================

3.1. Primary Culture of Neonatal Rat Cardiomyocytes
---------------------------------------------------

Primary culture of neonatal cardiomyocytes (CMs) was prepared from 1--3 days old Sprague-Dawley (SD) rats by the trypsin digestion method, as previously described \[[@B15-ijms-16-12482]\]. Briefly, rat ventricles were minced into pieces and subjected to 0.125% trypsin digestion in Hank\'s Balanced Salt Solution (HBSS). After 2 h of cell attachment to remove non-cardiomyocytes, CMs were collected and maintained for 48 h in DMEM/F12 containing 10% FBS with antibiotics. A supplement of 0.1 mmol/mL 5-bromo-2ʹ-deoxyuridine (Brdu, Sigma-Aldrich, St. Louis, MO, USA) was added to cultured medium to inhibit non-cardiomyocytes. Then the cells were deprived of serum for 24 h prior to experiments.

3.2. Apoptotic Cell Analysis by TUNEL Labeling
----------------------------------------------

TUNEL labeling was performed according to the manufacturer's protocol (*In situ* Cell Death Detection kit, Merck Inc., Billerica, MA, USA). The slides were incubated with 50 μL TUNEL reaction mixture containing TdT for 60 min at 37 °C, and then incubated with diaminobenzidine (DAB) substrate solution for 10 min. The apoptotic cells were expressed as a percentage of the TUNEL positive nuclei in all the nuclei of detected cell samples \[[@B52-ijms-16-12482]\]. Five fields per cell sample were evaluated and averaged. At least 3 cell samples of each group were analyzed.

3.3. H~2~S Measurement
----------------------

The H~2~S level in culture supernatant was indicated by sulfide using the method previously described with some modifications \[[@B53-ijms-16-12482]\]. Briefly, cells were cultured in phenol red-free DMEM supplemented with 10% FBS, and stimulated with 100 μM H~2~O~2~ with or without UII (0.1 μM, Sigma) pretreatment for the time periods as indicated. After that, 500 μL culture supernatants were collected and added into a test tube containing 250 μL 1% zinc acetate, followed by the addition with 133 μL of 20 mM *N*,*N*-dimethyl-*p*-phenylenediamine sulfate in 7.2 M HCl and 133 μL of 30 mM FeCl~3~ in 1.2 M HCl. Subsequently, the mixtures were incubated at room temperature for 20 min. Afterwards, the protein in the culture supernatant was removed by adding 250 μL 10% trichloroacetic acid; the absorbance of the resulting solution was detected at 670 nm by a microplate reader (Infinite M200, Tecan, Seestrasse, Switzerland). The H~2~S concentration was assessed by a standard curve of NaHS.

3.4. Reverse Transcription PCR (RT-PCR)
---------------------------------------

Total RNA was extracted from cardiomyocytes or liver tissue of male SD rats (200--250 g) with Trizol (Invitrogen, Carlsbad, CA, USA) following the manufacturer's instructions. Total RNA (1 μg) of each sample was reversely transcribed into cDNA using a cDNA synthesis kit (Fermentas, Burlington, ON, Canada). An equal volume of the resulting cDNA product was amplified using a PCR Master Mix kit (Fermentas, USA) with primers (Shenggong, Shanghai, China) as follows: rat CSE (NM_017074.1), forward: 5′-TCCGGATGGAGAAACACTTC-3′; reverse: 5′-CACCAGCATGTCCACCTTC-3′; CBS (NM_012522.2) forward: 5′-GCCAACTTCTGGCAACAC-3′, reverse: 5′-CACCAGCATGTCCACCTTC-3′) and GAPDH (forward 5′-AACAAGCAACTGTCCCTGAGC-3′, reverse: 5′-GTAGACAGAAGGTGGCACAGA-3′). The PCR conditions included denaturation at 94 °C for 3 min, followed by 30 repeated cycles of 95 °C for 30 s, 55 °C for 45 s and 72 °C for 45 s, and extension at 72 °C for 7 min. PCR products (372 bp for CSE, 307 bp for CBS) were separated in 2% agarose gels. The optical band densities were analyzed with Image software program (FR-200A, CapitalBio, Beijing, China).

3.5. SiRNA and in Vitro Transfection
------------------------------------

SiRNAs for CSE or UT were obtained from Shanghai GenePharma (Shanghai, China), and three different sequences targeted to rat CSE or UT were screened for the efficiency of knockdown CSE or UT in cardiomyocytes, respectively. Lipofectamin 2000 (Sigma-Aldrich, St. Louis, MO, USA) and siRNAs were mixed and kept still for 20 min at room temperature, and then the mixtures were added to cardiomyocytes cultured in 6-well plates for transfection. The scramble sequences were also transfected as controls.

3.6. Western Blot Analysis
--------------------------

Cultured cardiomyocytes were transfected with si-scramble or si-CSE for 48 h, treated with UII (0.1 μM) or PBS for 30 min, then exposed to 100 μM H~2~O~2~ for 10 min or 24 h, or cultured cardiomyocytes were treated with DMSO or U0126 (Sigma-Aldrich, St. Louis, MO, USA ) with or without UII for 30 min and exposed to 100 μM H~2~O~2~ for 10 min or 24 h. Protein was extracted from these cardiomyocytes with lysis buffer according to previous study \[[@B16-ijms-16-12482]\]. The protein samples were separated in 12% SDS-PAGE, transferred to polyvinylidene difluoride membranes (Gelman-Pall, Ann Arbor, MI, USA), and then incubated overnight at 4 °C with primary antibodies: GPR14 (1:500 Santa Cruz Biotechnology, Dallas, TX, USA), CSE (1:1000), phosphorylated ERK (1:5000), ERK(1:5000), Bcl-2 (1:1000) (all Cell Signaling Technology, Danvers, MA, USA) and Bax (6A7) (1:1000) (Abcam, Cambridge, MA, USA), followed by incubation with horseradish peroxidase (HRP)-conjugated secondary antibodies (1:1000) for 1 h at room temperature. And the results were developed by Pro-Light chemiluminescent detection kit (Tiangen Biotech Inc., Beijing, China) with LAS-3000 imaging system (FUJIFILM Inc., Tokyo, Japan).

3.7. Myocardial Infarction Model of Mouse and Real-Time Polymerase Chain Reaction (RT-PCR)
------------------------------------------------------------------------------------------

Please refer to "[Supplementary Methods](#app1-ijms-16-12482){ref-type="app"}".

3.8. Statistical Analysis
-------------------------

All the data were presented as mean ± SEM and were analyzed using One-Way ANOVA tests followed by Least-Significance-Difference (LSD) method for multiple means comparison or using Independent-Samples *t*-tests for two means comparison. A two-tailed *p*-value of \<0.05 was considered statistically significant. All statistical analysis was performed by Prism 6.0 (GraphPad Software. Inc, San Diego, CA, USA).

4. Conclusions
==============

Taken together, UII rapidly promoted the phosphorylation of ERK, and increased CSE level and H~2~S production, which in turn enhanced the p-ERK level and contributed to the anti-apoptosis of UII on cardiomyocytes under oxidative stress. This mechanism may be critical for the protective effect of UII on cardiac injury against ischemia reperfusion.
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